GTBP — GT BIOPHARMA INC
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
As of Q2 2026, 58 SEC-registered investment managers reported holding GTBP (GT BIOPHARMA INC) in their latest 13F filings, with a combined reported value of $1.15M across 2.37M shares. That is -8.6% by share count (-128.31K shares) versus the previous quarter, while reported value moved +9.1%. Ownership is concentrated: the five largest holders account for 52.7% of reported value and the top ten for 70.3%.
Compared with the prior quarter, 24 opened new positions, 6 added to existing stakes, 6 trimmed, 5 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
Major shareholders of GT BIOPHARMA INC (GTBP) include DekaBank Deutsche Girozentrale, GEODE CAPITAL MANAGEMENT, LLC, VANGUARD CAPITAL MANAGEMENT LLC, ranked by reported 13F value among the 98 institutional holders on this page.
GTBP is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q3 2026 | 20 | 51.39K | $305.78K | -95.3% |
| Q2 2026 | 58 | 2.37M | $1.15M | -8.6% |
| Q1 2026 | 39 | 1.61M | $656.72K | +103.7% |
| Q4 2025 | 37 | 481.01K | $372.16K | -21.0% |
| Q3 2025 | 20 | 231.84K | $138.67K | +1.6% |
| Q2 2025 | 21 | 198.68K | $711.26K | +115.3% |
| Q1 2025 | 20 | 99.69K | $220.50K | -11.7% |
| Q4 2024 | 18 | 90.51K | $279.06K | +8.9% |
Over the 8 quarters shown, institutional share counts decreased 43% in aggregate (Q4 2024 → Q3 2026); the largest single-quarter swing was Q2 2025 (+115.3%).
Top Institutional Holders (Q3 2026) — 20 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 15.05K | $97.41K | 0.00% | Reduce | |
| 10.24K | $66.25K | 0.00% | Reduce | |
| 9.04K | $58.47K | 0.00% | Reduce | |
| 5.41K | $35.03K | 0.00% | Add | |
| 2.30K | $14.87K | 0.00% | Reduce | |
| 1.60K | $10.35K | 0.00% | Reduce | |
| 1.28K | $8.46K | 0.00% | Reduce | |
| 1.02K | $6.61K | 0.00% | Reduce | |
| 4.50K | $2.21K | 0.00% | Hold | |
| 332 | $2.15K | 0.00% | Reduce | |
| 200 | $1.29K | 0.00% | New | |
| 120 | $776 | 0.00% | Reduce | |
| 100 | $647 | 0.00% | Reduce | |
| 66 | $427 | 0.00% | Reduce | |
| 60 | $413 | 0.00% | Reduce | |
| 25 | $162 | 0.00% | Reduce | |
| 20 | $129 | 0.00% | Reduce | |
| 20 | $129 | 0.00% | Reduce | |
| 1 | $6 | 0.00% | New | |
| 1 | $6 | 0.00% | Reduce |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q2 2026 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 376.40K | $184.44K | 0.00% | Reduce | |
| 266.79K | $130.65K | 0.00% | New | |
| 266.79K | $130.65K | 0.00% | Reduce | |
| 225.94K | $110.71K | 0.00% | Hold | |
| 107.14K | $52.00K | 0.00% | New | |
| 100.00K | $48.97K | 0.00% | New | |
| 93.63K | $45.85K | 0.00% | Hold | |
| 81.81K | $40.06K | 0.01% | New | |
| 75.46K | $36.95K | 0.00% | New | |
| 64.00K | $31.34K | 0.01% | New | |
| 64.00K | $31.34K | 0.01% | New | |
| 55.94K | $27.39K | 0.00% | New | |
| 50.10K | $24.53K | 0.00% | Hold | |
| 50.00K | $24.48K | 0.02% | New | |
| 40.00K | $19.60K | 0.00% | New | |
| 38.50K | $18.86K | 0.00% | Add | |
| 36.38K | $17.82K | 0.00% | Add | |
| 22.57K | $11.05K | 0.00% | Add | |
| 20.77K | $10.17K | 0.00% | Hold | |
| 20.01K | $9.80K | 0.00% | Hold | |
| 20.00K | $9.79K | 0.00% | New | |
| 20.00K | $9.79K | 0.00% | Hold | |
| 20.00K | $9.79K | 0.00% | New | |
| 23.26K | $8.67K | 0.00% | Add | |
| 16.50K | $8.08K | 0.01% | Hold |
Q1 2026 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 451.88K | $184.37K | 0.00% | New | |
| 294.46K | $120.17K | 0.00% | Add | |
| 225.94K | $92.18K | 0.00% | New | |
| 93.63K | $38.21K | 0.00% | New | |
| 66.17K | $27.00K | 0.00% | Reduce | |
| 50.00K | $20.41K | 0.00% | Hold | |
| 45.97K | $18.76K | 0.00% | Add | |
| 31.80K | $12.98K | 0.00% | Add | |
| 30.38K | $12.40K | 0.00% | Add | |
| 23.40K | $9.55K | 0.00% | New | |
| 21.00K | $8.57K | 0.00% | Add | |
| 20.77K | $8.47K | 0.00% | New | |
| 20.02K | $8.17K | 0.00% | Add | |
| 20.01K | $8.16K | 0.00% | Hold | |
| 20.00K | $8.16K | 0.00% | New | |
| 16.60K | $6.77K | 0.00% | Reduce | |
| 16.50K | $6.73K | 0.00% | Hold | |
| 16.04K | $6.54K | 0.00% | Hold | |
| 14.76K | $6.02K | 0.00% | New | |
| 15.00K | $6.00K | 0.00% | Hold | |
| 17.09K | $6.00K | 0.00% | Hold | |
| 14.88K | $6.00K | 0.00% | New | |
| 12.00K | $4.90K | 0.00% | Reduce | |
| 12.00K | $4.89K | 0.00% | Hold | |
| 11.00K | $4.49K | 0.00% | New |
Q4 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 80.76K | $63.41K | 0.00% | Add | |
| 54.74K | $42.99K | 0.03% | New | |
| 50.00K | $36.62K | 0.00% | New | |
| 26.02K | $20.43K | 0.00% | New | |
| 20.01K | $15.71K | 0.00% | New | |
| 19.26K | $15.12K | 0.00% | Reduce | |
| 18.60K | $14.60K | 0.00% | Add | |
| 17.09K | $13.00K | 0.00% | New | |
| 16.50K | $12.96K | 0.01% | New | |
| 16.04K | $12.59K | 0.00% | Add | |
| 15.00K | $12.00K | 0.00% | New | |
| 15.00K | $11.78K | 0.00% | New | |
| 13.00K | $10.21K | 0.00% | New | |
| 12.53K | $9.84K | 0.00% | Reduce | |
| 12.00K | $9.42K | 0.00% | New | |
| 11.77K | $9.00K | 0.00% | New | |
| 10.90K | $8.56K | 0.00% | New | |
| 10.83K | $8.51K | 0.00% | Reduce | |
| 10.63K | $8.35K | 0.00% | New | |
| 10.00K | $7.85K | 0.00% | New | |
| 8.41K | $6.60K | 0.00% | Reduce | |
| 10.00K | $5.39K | 0.00% | New | |
| 5.00K | $3.93K | 0.00% | New | |
| 3.75K | $2.94K | 0.00% | Hold | |
| 3.00K | $2.36K | 0.00% | New |
Q3 2025 — 20 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 92.53K | $54.59K | 0.00% | Hold | |
| 39.63K | $23.56K | 0.00% | New | |
| 23.97K | $14.25K | 0.00% | Add | |
| 17.07K | $10.01K | 0.00% | New | |
| 14.02K | $8.22K | 0.00% | Add | |
| 10.50K | $6.25K | 0.00% | Hold | |
| 10.01K | $5.87K | 0.00% | Hold | |
| 9.74K | $5.71K | 0.00% | Hold | |
| 5.07K | $4.70K | 0.00% | Reduce | |
| 3.75K | $2.20K | 0.00% | Add | |
| 2.63K | $1.54K | 0.00% | Reduce | |
| 1.70K | $999 | 0.00% | Add | |
| 865 | $508 | 0.00% | Hold | |
| 300 | $230 | 0.00% | Hold | |
| 24 | $14 | 0.00% | Reduce | |
| 16 | $9 | 0.00% | Hold | |
| 10 | $6 | 0.00% | Hold | |
| 5 | $3 | 0.00% | Reduce | |
| 1 | $1 | 0.00% | Hold | |
| 1 | $1 | 0.00% | Hold |
Q2 2025 — 21 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 92.53K | $331.26K | 0.00% | Add | |
| 26.30K | $94.15K | 0.00% | New | |
| 23.84K | $85.35K | 0.00% | Add | |
| 11.46K | $41.01K | 0.00% | Add | |
| 10.50K | $37.60K | 0.00% | Hold | |
| 10.01K | $35.84K | 0.00% | Hold | |
| 9.74K | $34.86K | 0.00% | Hold | |
| 5.81K | $20.80K | 0.00% | Add | |
| 4.01K | $14.37K | 0.00% | Add | |
| 2.75K | $9.85K | 0.00% | Add | |
| 865 | $3.10K | 0.00% | New | |
| 450 | $1.61K | 0.00% | Reduce | |
| 300 | $1.06K | 0.00% | New | |
| 46 | $165 | 0.00% | New | |
| 29 | $104 | 0.00% | Add | |
| 16 | $57 | 0.00% | Add | |
| 10 | $36 | 0.00% | Hold | |
| 6 | $21 | 0.00% | Reduce | |
| 1 | $4 | 0.00% | Hold | |
| 1 | $4 | 0.00% | Hold | |
| 1 | $4 | 0.00% | Hold |
New Positions (Q2 2026)
- GEODE CAPITAL MANAGEMENT, LLC 266.79K sh · $130.65K
- HRT FINANCIAL LP 107.14K sh · $52.00K
- Everhart Financial Group, Inc. 100.00K sh · $48.97K
- Opal Wealth Advisors, LLC 81.81K sh · $40.06K
- Northern Trust Corp 75.46K sh · $36.95K
- 49 WEALTH MANAGEMENT, LLC 64.00K sh · $31.34K
- ALONGSIDE, LLC 64.00K sh · $31.34K
- Cetera Investment Advisers 55.94K sh · $27.39K
- KITCHING PARTNERS, LLC 50.00K sh · $24.48K
- PNC Financial Services 40.00K sh · $19.60K
- Corient Private Wealth LP 20.00K sh · $9.79K
- SAGESPRING WEALTH PARTNERS, LLC 20.00K sh · $9.79K
Fully Exited (vs previous quarter)
- Citadel Advisors sold 66.17K sh · $27.00K
- Invst, LLC sold 23.40K sh · $9.55K
- Cerity Partners LLC sold 20.02K sh · $8.17K
- Virtu Financial LLC sold 14.88K sh · $6.00K
- Fidelity Management & Research (FMR) sold 1.00K sh · $408
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | 15.05K | 376.40K | 451.88K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Geode Capital Management | 10.24K | 266.79K | 294.46K | 19.26K | 23.97K | 23.84K | 23.09K | 14.90K | 15.04K | 11.18K | 11.18K | 337.31K | 337.31K | — | — | 223.44K | — | — | — | — |
| VANGUARD FIDUCIARY TRUST CO | 9.04K | 225.94K | 225.94K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| UBS Group AG | 5.41K | 2 | 45.97K | 1 | 2.63K | 5.81K | 2.56K | 5.00K | 3.90K | 8.98K | 1.02K | 14.61K | 8.75K | — | — | — | — | — | — | — |
| Arax Advisory Partners | 2.30K | 93.63K | 93.63K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| PNC Financial Services | 1.60K | 40.00K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| OSAIC HOLDINGS, INC. | 1.28K | 38.50K | 21.00K | 2.00K | 5.07K | 11.46K | 2.71K | 2.65K | 12 | 12 | 32 | 1.02K | 1.27K | — | — | — | — | — | — | — |
| Morgan Stanley | 1.02K | 22.57K | 16.60K | 18.60K | 14.02K | 4.01K | 3.53K | 3.53K | 266 | 266 | 266 | 8.08K | 8.08K | — | — | — | — | — | — | — |
| Allworth Financial LP | 4.50K | 4.50K | 4.50K | 1 | 1 | 1 | 1 | 2 | — | — | — | — | — | — | — | — | — | — | — | — |
| BlackRock Inc | 332 | 8.31K | 8.41K | 8.41K | 9.74K | 9.74K | 9.74K | 9.74K | 9.74K | — | — | — | — | — | — | — | — | — | — | — |
| Main Street Group, LTD | 200 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Farther Finance Advisors, LLC | 120 | 3.00K | 3.00K | 3.00K | — | — | 6 | 6 | — | — | — | — | — | — | — | — | — | — | — | — |
| West Financial Advisors, LLC | 100 | 2.50K | 2.50K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Triumph Capital Management | 66 | 1.66K | 1.66K | 1.66K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| JONES FINANCIAL COMPANIES LLLP | 60 | 1.50K | — | — | 300 | 300 | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Reyes Financial Architecture, Inc. | 25 | 625 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Global Retirement Partners, LLC | 20 | 500 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| HARBOUR INVESTMENTS, INC. | 20 | 500 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Fidelity Management & Research (FMR) | 1 | — | 1.00K | — | — | — | — | — | — | — | 61 | — | 150 | — | — | — | — | — | — | — |
| IFG Advisory, LLC | 1 | 33 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details
FAQ
Which funds hold GTBP?
As of 2026-Q2, 58 institutional funds reported holding GTBP (GT BIOPHARMA INC) in SEC 13F filings, with a combined reported value of $1.15M.
How many shares of GTBP do institutions own?
13F filers reported 2.37M shares of GTBP, worth $1.15M in aggregate at the end of 2026-Q2.
Is institutional ownership of GTBP rising or falling?
Share counts moved -8.6% versus the prior quarter — distribution.
Who are the top institutional holders of GTBP?
The largest 13F holders are DekaBank Deutsche Girozentrale, GEODE CAPITAL MANAGEMENT, LLC, VANGUARD CAPITAL MANAGEMENT LLC, Renaissance Technologies, Geode Capital Management; the top 25 are ranked at the top of this page.
Who are the major shareholders of GT BIOPHARMA INC?
The major shareholders of GT BIOPHARMA INC (GTBP) by reported 13F value are DekaBank Deutsche Girozentrale, GEODE CAPITAL MANAGEMENT, LLC, VANGUARD CAPITAL MANAGEMENT LLC, Renaissance Technologies, Geode Capital Management, among 98 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.